Biotech stocks are surging. How investors can play the new drug innovation boom
Source: CNBC Markets ·
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Read the full story at CNBC Markets
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.